Authors:
McDonnell, SK
Schaid, DJ
Myers, JL
Grant, CS
Donohue, JH
Woods, JE
Frost, MH
Johnson, JL
Sitta, DL
Slezak, JM
Crotty, TB
Jenkins, RB
Sellers, TA
Hartmann, LC
Citation: Sk. Mcdonnell et al., Efficacy of contralateral prophylactic mastectomy in women with a personaland family history of breast cancer, J CL ONCOL, 19(19), 2001, pp. 3938-3943
Authors:
Roberts, WW
Bergstralh, EJ
Blute, ML
Slezak, JM
Carducci, M
Han, M
Epstein, JI
Eisenberger, MA
Walsh, PC
Partin, AW
Citation: Ww. Roberts et al., Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy, UROLOGY, 57(6), 2001, pp. 1033-1037
Authors:
Roberts, SG
Blute, ML
Bergstralh, EJ
Slezak, JM
Zincke, H
Citation: Sg. Roberts et al., PSA doubling time as a predictor of clinical progression after biochemicalfailure following radical prostatectomy for prostate cancer, MAYO CLIN P, 76(6), 2001, pp. 576-581
Authors:
Amling, CL
Bergstralh, EJ
Blute, ML
Slezak, JM
Zincke, H
Citation: Cl. Amling et al., Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?, J UROL, 165(4), 2001, pp. 1146-1151
Authors:
Frost, MH
Schaid, DJ
Sellers, TA
Slezak, JM
Arnold, PG
Woods, JE
Petty, PM
Johnson, JL
Sitta, DL
McDonnell, SK
Rummans, TA
Jenkins, RB
Sloan, JA
Hartmann, LC
Citation: Mh. Frost et al., Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy, J AM MED A, 284(3), 2000, pp. 319-324
Authors:
Blute, ML
Bergstralh, EJ
Partin, AW
Walsh, PC
Kattan, MW
Scardino, PT
Montie, JE
Pearson, JD
Slezak, JM
Zincke, H
Citation: Ml. Blute et al., Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer, J UROL, 164(5), 2000, pp. 1591-1595
Authors:
Sato, K
Qian, JQ
Slezak, JM
Lieber, MM
Bostwick, DG
Bergstralh, EJ
Jenkins, RB
Citation: K. Sato et al., Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma, J NAT CANC, 91(18), 1999, pp. 1574-1580
Authors:
Brown, MJA
Slezak, JM
Lieber, MM
Jenkins, RB
Citation: Mja. Brown et al., Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radicalprostatectomy, MAYO CLIN P, 74(12), 1999, pp. 1214-1220
Authors:
Sweat, SD
Pacelli, A
Bergstralh, EJ
Slezak, JM
Cheng, L
Bostwick, DG
Citation: Sd. Sweat et al., Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery, J UROL, 161(4), 1999, pp. 1233-1237
Authors:
Amling, CL
Lerner, SE
Martin, SK
Slezak, JM
Blute, ML
Zincke, H
Citation: Cl. Amling et al., Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer, J UROL, 161(3), 1999, pp. 857-862